Spain· ES:77628
LAMIVUDINA AUROVITAS 300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
A medicinal product containing lamivudina, registered in Spain by Aurovitas Spain, S.A.U..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- lamivudina
- Manufacturer
- Aurovitas Spain, S.A.U.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- August 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lamivudina in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEPIVIRViiV Healthcare BV, Amersfoort
- United StatesEPIVIRViiV Healthcare Company
- FranceEPIVIR 300 mg, comprimé pelliculéVIIV HEALTHCARE UK (ROYAUME-UNI)
- NetherlandsEpivir 300 mg, omhulde tablettenViiV healthcare B.V.
- BelgiumEpivir 300 mgViiV Healthcare
- FinlandEpivirViiV Healthcare BV
- IcelandEpivirViiV Healthcare BV
- IrelandEpivir 300 mg film-coated tabletsViiV Healthcare BV
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Lamivudin Sandoz
- Cyprus · Lamivudine Normon
- Germany · Lamivudin Aurobindo, Lamivudin Mylan
- France · Lamivudine Arrow, Lamivudine Sandoz
- United Kingdom (Northern Ireland) · Lamivudine Amarox, Lamivudine Generics
- Iceland · Epivir, Lamivudine Teva
- Italy · Lamivudina Aurobindo, Lamivudina Aurobindo Italia
- Liechtenstein · Epivir, Lamivudine Teva
- Netherlands · Lamivudine Accord, Lamivudine Aurobindo
- Norway · Epivir, Lamivudine Teva
- Poland · Lamivudine Aurovitas
- Portugal · Lamivudina Aurobindo, Lamivudina Farmoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/38be7a3e-b39b-4444-85ec-23182820f984 GET /v1/drugs/38be7a3e-b39b-4444-85ec-23182820f984?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Diagnóstico Hospitalario",
"estado": "{\"aut\":1371074400000}",
"nregistro": "77628",
"substance": "lamivudina"
}See everything about lamivudina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.